ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

T-Lymphocytes, Cytotoxic

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Cells ∟ Blood Cells ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic Medical Subject Headings (MeSH) ∟ Fluids and Secretions ∟ Body Fluids ∟ Blood ∟ Blood Cells ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic Medical Subject Headings (MeSH) ∟ Hemic and Immune Systems ∟ Blood ∟ Blood Cells ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic Medical Subject Headings (MeSH) ∟ Hemic and Immune Systems ∟ Immune System ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic X
Broader terms:	Medical Subject Headings (MeSH) ∟ Cells ∟ Blood Cells ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic Medical Subject Headings (MeSH) ∟ Fluids and Secretions ∟ Body Fluids ∟ Blood ∟ Blood Cells ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic Medical Subject Headings (MeSH) ∟ Hemic and Immune Systems ∟ Blood ∟ Blood Cells ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic Medical Subject Headings (MeSH) ∟ Hemic and Immune Systems ∟ Immune System ∟ Leukocytes ∟ Leukocytes, Mononuclear ∟ Lymphocytes ∟ T-Lymphocytes ∟ CD8-Positive T-Lymphocytes ∟ T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes > T-Lymphocytes > Lymphocytes > Leukocytes, Mononuclear > Leukocytes > Blood Cells > Cells > Medical Subject Headings (MeSH) CD8-Positive T-Lymphocytes > T-Lymphocytes > Lymphocytes > Leukocytes, Mononuclear > Leukocytes > Blood Cells > Blood > Body Fluids > Fluids and Secretions > Medical Subject Headings (MeSH) CD8-Positive T-Lymphocytes > T-Lymphocytes > Lymphocytes > Leukocytes, Mononuclear > Leukocytes > Blood Cells > Blood > Hemic and Immune Systems > Medical Subject Headings (MeSH) CD8-Positive T-Lymphocytes > T-Lymphocytes > Lymphocytes > Leukocytes, Mononuclear > Leukocytes > Immune System > Hemic and Immune Systems > Medical Subject Headings (MeSH) X
Annotation:	subpopulations: coord IM with T-LYMPHOCYTE SUBSETS (IM) X
History note:	Cytotoxicity, Immunologic (1978-1982) \| T Lymphocytes (1973-1982)X
historyNote*:	90; was T LYMPHOCYTES, CYTOTOXIC 1983-89 X
onlineNote*:	use T-LYMPHOCYTES, CYTOTOXIC to search T LYMPHOCYTES, CYTOTOXIC 1983-89 X
publicMeSHNote*:	90; was T LYMPHOCYTES, CYTOTOXIC 1983-89 X
Scope note:	Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from natural killer cells (KILLER CELLS, NATURAL) and from KILLER CELLS mediating antibody-dependent cell cytotoxicity. There are two effector phenotypes: TC1 and TC2. X
activeMeSHYear*:	2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1982-04-29X
dateEstablished*:	1983-01-01X
dateRevised*:	2003-07-09X
recordAuthorizer*:	sjnX
recordMaintainer*:	jmpX
recordOriginator*:	SAGX
Type:	Concept X
URI:	X
Labels and equivalent concepts:	Sytotoksiset T-imusolut (fi) Tappaja-T-imusolu (fi, replaced) Sytotoksiset T-solut (fi, replaced) Sytotoksiset T-lymfosyytit (fi, replaced) Tappaja-T-imusolut (fi, replaced) Tappaja-T-lymfosyytit (fi, replaced) Tappaja-T-solut (fi, replaced) Tappaja-T-solu (fi, replaced) Tappaja-T-lymfosyytti (fi, replaced) Sytotoksinen T-solu (fi, replaced) Sytotoksinen T-lymfosyytti (fi, replaced) Sytolyyttinen T-lymfosyytti (fi, replaced) Sytolyyttinen T-imusolu (fi, replaced) Sytolyyttinen T-solu (fi, replaced) Sytolyyttiset T-imusolut (fi, replaced) Sytotoksinen T-imusolu (fi, replaced) Sytolyyttiset T-solut (fi, replaced) Sytolyyttiset T-lymfosyytit (fi, replaced) T-lymfocyter, cytotoxiska (sv) Cytotoxic T-Lymphocytes (en, replaced) Cell-Mediated Lympholytic Cells (en, replaced) X
Share:	X